Did you know?

Emergent BioSolutions Reports FDA Advisory Committees’ Unanimous Vote in Favor of NARCAN® (naloxone HCI) Nasal Spray for Over-the-Counter Use. February 15, 2023 17:19 ET ...Emergent BioSolutions, Inc. (EBS) CEO Robert Kramer on Q1 2021 Results - Earnings Call Transcript SA Transcripts Fri, Apr. 30, 2021 Emergent Biosolutions (EBS) Presents At KeyBanc Life Sciences ...As you can see below, at the end of December 2022, Emergent BioSolutions had US$1.41b of debt, up from US$847.1m a year ago. Click the image for more detail. However, because it has a cash reserve of US$651.1m, its net debt is less, at about US$754.7m. NYSE:EBS Debt to Equity History April 5th 2023.Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. [2] It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes. Stock Quote & Chart. Data Provided by Refinitiv. Minimum 15 minutes delayed. The Investor Relations website contains information about Emergent BioSolutions Inc.'s business for stockholders, potential investors, and financial analysts. The FDA approved Emergent BioSolutions Inc's (NYSE:EBS) anthrax vaccine for adults aged 18 through 65.. The vaccine Cyfendus (Anthrax Vaccine Adsorbed, Adjuvanted), previously known as AV7909, is ...Emergent BioSolutions Inc EBS Morningstar Rating Unlock Stock XNYS Rating as of Nov 29, 2023 Summary Chart News Price vs Fair Value Sustainability …Emergent BioSolutions Inc. 2.15. Delayed Data. As of Nov 29. +0.14 / +6.97%. Today’s Change. 1.81. Today ||| 52-Week Range. 16.66.Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...The latest price target for Emergent BioSolutions ( NYSE: EBS) was reported by Benchmark on Tuesday, August 29, 2023. The analyst firm set a price target for 0.00 expecting EBS to fall to within ...Get the latest Emergent BioSolutions Inc. (EBS) stock news and headlines to help you in your trading and investing decisions.World at Work category Emergent BioSolutions to lay off about 400 employees August 8, 2023 article with gallery Business category US FDA approves …Emergent BioSolutions Inc. shareholders can proceed in part with a lawsuit over sharp stock declines following news of contaminated Covid-19 vaccine batches at the company’s production facility and a canceled government contract, a federal court ruled. The investors plausibly alleged numerous intentional, material misrepresentations and ...Mar 30, 2023 · Shares of Emergent BioSolutions ( EBS) were soaring 11% higher as of 11:13 a.m. ET on Thursday. The big gain came after the Food and Drug Administration (FDA) approved the company's Narcan on ... Emergent Biosolutions Inc (EBS) stock is trDec 1, 2023 · Emergent BioSolutions stock has See the latest Emergent BioSolutions Inc stock price (EBS:XNYS), related news, valuation, dividends and more to help you make your investing decisions.Feb 27, 2023 · Emergent Biosolutions (EBS) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of $0.32. This compares to earnings of $4.50 per share a year ago. Emergent BioSolutions Reports Financial R Emergent Biosolutions Inc Stock Price History. Emergent Biosolutions Inc’s price is currently up 19.5% so far this month. During the month of April, Emergent Biosolutions Inc’s stock price has reached a high of $12.56 and a low of $9.47. Over the last year, Emergent Biosolutions Inc has hit prices as high as $43.46 and as low as $7.74. EBS - Emergent Biosolutions Inc - Stock screener fo

Emergent BioSolutions Awarded 10-Year BARDA Contract Valued at up to a Maximum of $704 Million for Advanced Development and Procurement of Ebanga™ Treatment for Ebola. 07/25/23. Emergent BioSolutions to Release Second Quarter 2023 Financial Results and Conduct Conference Call on August 8, 2023. 07/20/23.Emergent BioSolutions announced Thursday that the US Food and Drug Administration will allow it to resume the manufacturing of the drug substance that goes into Johnson & Johnson’s Covid-19 vaccine.Feb 16, 2023 · Emergent Biosolutions EBS shares ended the last trading session 12.5% higher at $14.92. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. Emergent Biosolutions Inc Stock Price History. Emergent Biosolutions Inc’s price is currently up 3.96% so far this month. During the month of May, Emergent Biosolutions Inc’s stock price has reached a high of $10.88 and a low of $8.20. Over the last year, Emergent Biosolutions Inc has hit prices as high as $40.45 and as low as $7.74.Aug 22, 2023 · Shares of Emergent BioSolutions ( EBS 11.68%) were tumbling 10.6% lower as of 11:29 a.m. ET on Tuesday. The decline came after S&P Global 's S&P Dow Jones Indices announced that Advance Auto Parts ...

Emergent BioSolutions Contacts: Media: Matt Hartwig Senior Director, Media Relations 240-760-0551 [email protected] Investors: Rich Lindahl Executive Vice President & Chief Financial Officer 240-631-3360 [email protected]. Source: Emergent BioSolutionsShares of Emergent BioSolutions ( EBS -3.30%) were falling 4% as of 11:07 a.m. EDT on Thursday after sinking as much as 7.6% earlier in the day. The stock tumbled earlier this week after the ...Emergent Biosolutions (EBS) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of $0.32. This compares to earnings of $4.50 per share a year ago.…

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Nov. 4, 2021. WASHINGTON — The federal government has can. Possible cause: 25 thg 4, 2021 ... The chief of Emergent BioSolutions made sales of sto.